[Multimodal imaging of lattice corneal dystrophy].
Minot M, Levy N, Proust H, Denis D.
J Fr Ophtalmol. 2022 Feb;45(2):249-250. doi: 10.1016/j.jfo.2021.06.033. Epub 2022 Jan 13.
Hereditary transthyretin amyloidosis overview.
Manganelli F, Fabrizi GM, Luigetti M, Mandich P, Mazzeo A, Pareyson D.
Neurol Sci. 2022 Dec;43(Suppl 2):595-604. doi: 10.1007/s10072-020-04889-2. Epub 2020 Nov 14.
Transthyretin amyloid cardiomyopathy.
Garcia-Pavia P, Domínguez F, Gonzalez-Lopez E.
Med Clin (Barc). 2021 Feb 12;156(3):126-134. doi: 10.1016/j.medcli.2020.06.064. Epub 2020 Oct 31.
ATTR Epidemiology, Genetics, and Prognostic Factors.
Obi CA, Mostertz WC, Griffin JM, Judge DP.
Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):17-26. doi: 10.14797/mdcvj.1066. eCollection 2022.
Clinical and Histopathologic Characteristics and Template of the TGFBI p.(His626Arg) Missense Variant Lattice Corneal Dystrophy.
Jaakkola AM, Kivelä TT.
Cornea. 2023 Sep 1;42(9):1124-1132. doi: 10.1097/ICO.0000000000003247. Epub 2023 Feb 10.
Familial amyloid polyneuropathy.
Planté-Bordeneuve V, Said G.
Lancet Neurol. 2011 Dec;10(12):1086-97. doi: 10.1016/S1474-4422(11)70246-0.
Cardiac amyloidosis: An update on diagnosis and treatment.
Donnelly JP, Hanna M.
Cleve Clin J Med. 2017 Dec;84(12 Suppl 3):12-26. doi: 10.3949/ccjm.84.s3.02.
Guideline of transthyretin-related hereditary amyloidosis for clinicians.
Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon BG, Ikeda S, Lewis WD, Obici L, Planté-Bordeneuve V, Rapezzi C, Said G, Salvi F.
Orphanet J Rare Dis. 2013 Feb 20;8:31. doi: 10.1186/1750-1172-8-31.
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.
Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, Gospodinova M, Obici L, Rapezzi C, Garcia-Pavia P.
JACC Heart Fail. 2019 Aug;7(8):709-716. doi: 10.1016/j.jchf.2019.04.010. Epub 2019 Jul 10.
Microbial keratitis in lattice corneal dystrophy: microsporidia as a new cause.
Dutta A, Das S, Priyadarshini SR, Mishra DK.
BMJ Case Rep. 2023 Dec 19;16(12):e255143. doi: 10.1136/bcr-2023-255143.
